Cost effectiveness of cervical cancer screening strategies in Tunisia;Cout efficacité des stratégies de dépistage du cancer du col utérin en Tunisie

Tunisie Medicale

Volumn 78, Issue 10, 2000, Pages 557-561

  Hsaïri, Mohamed ^a   Fakhfakh, Radhouane ^a   Ghyoula, Mohamed ^b   Abdallah, Mansour Ben ^c   Achour, Noureddine ^a  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

^c SALAH AZAIEZ INSTITUTE   (Tunisia)

Author keywords

Cervical cancer ; Cost effictiveness; Screening

Indexed keywords

AGE; AGE DISTRIBUTION; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; EVALUATION; FEMALE; HUMAN; MASS SCREENING; METHODOLOGY; PATIENT SELECTION; TIME; TUNISIA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

AGE DISTRIBUTION; AGE FACTORS; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; FEMALE; HUMANS; MASS SCREENING; PATIENT SELECTION; TIME FACTORS; TUNISIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034305476     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five continents. vol VII. IARC, Scientific Publications, no 143,1997.
2. Hakama M. Trends in the incidence of cervical cancer in Nordic countries. In : Magnus K, ed. Trends in cancer incidence. Washington, DC, Hemisphere 1982.
3. Conférence de consensus sur le dépistage du cancer du col utérin. 1990.XXXIIIe Congrès de la Fédération des gynécologues et obstétriciens de langue française. Lille,5-6-7 Septembre 1990. J. Gynecol Obstetr Reprod,19(5bis).
4. Soutter WP, Fletcher A. Invasive cancer in women with mild dyskaryosis followed up cytologically. Br Med J,1994 308:1421-1423.
5. Bosch Fx, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer:a worlwide perspective. J Natl Cancer Inst 1995,87:796-802.
6. Hildesheim A, Schiffman MH, Gravit P et al. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon. J Infect Dis,1994,169:235-240.
7. Munoz N, Bosch Fx, DE Sanjoses et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in spain and colombia. Cancer Epidemiol Biomark Prev,1993,2,423-431.
8. Schiffman Mh, Baver HM, Hoover Rn et al. Epidemiologic evidence showing that human papillomavirus causes most cervical intraepithelial neoplasia. J Natl Cancer Inst,1993,85:958-964.
9. Butter worth CE JR, Hatch KD, Macaluso M et al. Folate deficiency and cervical dysplasia. JAMA,1992,267:528-533.
10. Koutsky LA, Holmes KK, Critchlow CN et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infections. N Engl J. Med,1992,327:1272-1278.
11. 11-Groupe Registre du cancer du Nord - Incidence des cancers dans la région du Nord pour l'année 1994. Rapport sous presse.
12. 12-Anonyme. Tarifs et nomenclature des actes professionnels des médecins, biologistes, chirurgiens dentistes, sages-femmes et auxiliaires médicaux. Publications de l'Imprimerie Officielle de la République Tunisienne,1995.
13. 13-Institut National de Statistique - Projections de la population 1995-2015 - Niveau régional volume II Tunis, INS, 1996.
14. Rothman K J. - Modern Epidemiology. Boston, Little, Brown, 1986, 35-40.
15. La Vecchia C, Decarli A, Gentile A, et al. "Pap" smear and the risk of cervical neoplasia : quantitative estimates from a case-control study. Lancet,1984, 2:779-782.
16. Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int Epidemiol,1988, 17:501-508.
17. Christopherson WM, Parker JE, Mendez WM, et al. Cervix center death rates and mass cytologic screening. Cancer,1970,26:808-811.
18. Peterson O. Spontaneous course of cervical precancerous conditions. Am J. Obstet Gynecol,1956,72:1063-1071.
19. Hill GB. Mortality from malignant neoplasm of the uterus since 1950. World Health Stat Rep, 1975,28:323-327.
20. Sox HC, Blatt MA, Higgins MC, Marton KI - Medical décision making Butterworths, Boston,1988.
21. Muir C, Waterhouse J, Mak T, Powell J, Whealan. Cancer Incidence in Five continents. IARC Scientific Publication 88,vol V,Lyon,1988.
22. Schaffer P, Anthon YS, Allemand H.. Would higher frequency of smear tests lead to the preventions of cervical cancer p.193-204.In:Monsonego (ed), Papilloma Virus in Human Pathology. ARES. SERONO,1-551,1995.
23. Water house J, Muir C, Shanmugaratna M, Powell J. Cancer Incidence in five continents IARC Scientific Publication,88,vol IV, Lyon, 1-812, 1982.